Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 7
2004 2
2005 6
2006 2
2007 3
2008 4
2009 1
2010 5
2011 9
2012 1
2013 7
2014 9
2015 7
2016 7
2017 12
2018 11
2019 8
2020 13
2021 14
2022 5
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy in cholangiocarcinoma.
Al-Rajabi R, Sun W. Al-Rajabi R, et al. Among authors: sun w. Curr Opin Gastroenterol. 2021 Mar 1;37(2):105-111. doi: 10.1097/MOG.0000000000000715. Curr Opin Gastroenterol. 2021. PMID: 33507028 Review.
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH. Fuchs CS, et al. Among authors: sun w. JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013. Epub 2018 May 10. JAMA Oncol. 2018. PMID: 29543932 Free PMC article. Clinical Trial.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Shitara K, Özgüroğlu M, Bang YJ, Di Bartolomeo M, Mandalà M, Ryu MH, Fornaro L, Olesiński T, Caglevic C, Chung HC, Muro K, Goekkurt E, Mansoor W, McDermott RS, Shacham-Shmueli E, Chen X, Mayo C, Kang SP, Ohtsu A, Fuchs CS; KEYNOTE-061 investigators. Shitara K, et al. Lancet. 2018 Jul 14;392(10142):123-133. doi: 10.1016/S0140-6736(18)31257-1. Epub 2018 Jun 4. Lancet. 2018. PMID: 29880231 Clinical Trial.
The Role of Angiogenesis in Hepatocellular Carcinoma.
Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, Finn RS. Morse MA, et al. Among authors: sun w. Clin Cancer Res. 2019 Feb 1;25(3):912-920. doi: 10.1158/1078-0432.CCR-18-1254. Epub 2018 Oct 1. Clin Cancer Res. 2019. PMID: 30274981 Review.
Recent advances in cancer immunotherapy.
Sun W. Sun W. J Hematol Oncol. 2017 Apr 24;10(1):96. doi: 10.1186/s13045-017-0460-9. J Hematol Oncol. 2017. PMID: 28434404 Free PMC article. No abstract available.
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.
Saeed A, Park R, Dai J, Al-Rajabi R, Kasi A, Baranda J, Williamson S, Saeed A, Ripp J, Collins Z, Mulvaney K, Shugrue M, Firth-Braun J, Godwin AK, Madan R, Phadnis M, Sun W. Saeed A, et al. Among authors: sun w. Cell Rep Med. 2023 Feb 21;4(2):100916. doi: 10.1016/j.xcrm.2023.100916. Epub 2023 Jan 25. Cell Rep Med. 2023. PMID: 36702123 Free PMC article. Clinical Trial.
Controversies in Rectal Cancer Treatment and Management.
Sun W, Al-Rajabi R, Perez RO, Abbasi S, Ash R, Habr-Gama A. Sun W, et al. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-11. doi: 10.1200/EDBK_279871. Am Soc Clin Oncol Educ Book. 2020. PMID: 32239978 Free article. Review.
Pass quantity, focus on quality.
Liu D, Sun W, Hou J, Yuan R, Li Z. Liu D, et al. Among authors: sun w. J Hematol Oncol. 2015 Mar 18;8:27. doi: 10.1186/s13045-015-0123-7. J Hematol Oncol. 2015. PMID: 25886529 Free PMC article.
135 results